🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Two year study to determine the safety and efficacy of weekly 35 mg Risedro...
Status
Completed
Location
Research Site
Start Date
2002-06
Trial ID
NCT00619957
Treatments Being Tested
Prostate cancer patients treated with LHRH agonists (e.g., leuprolide) lose...
Status
Completed
Location
Southern Interior Medical Research Corporation
Start Date
2007-01
Trial ID
NCT00426777
Treatments Being Tested
Children with Osteogenesis Imperfecta (OI) have bone pain, low bone mass an...
Status
Completed
Location
Miami Children's Hospital
Start Date
2004-11
Trial ID
NCT00106028
Treatments Being Tested
This study is to evaluate and compare the effects of Alendronate and Risedr...
Status
Completed
Location
Multiple Locations
Start Date
2002-09-01
Trial ID
NCT00092014
Men treated with neoadjuvant luteinizing hormone-releasing hormone (LHRH)-a...
Status
Completed
Location
University of Connecticut Health Center
Start Date
2003-01
Trial ID
NCT00859027
Treatments Being Tested
The purpose of the study is to learn if one year of treatment with parathyr...
Status
Completed
Location
UC Davis General Medicine Research Clinic
Start Date
2005-09
Trial ID
NCT00221299
Treatments Being Tested
The present phase II/III, multicenter, randomized, double-blind, parallel g...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02063854
Treatments Being Tested
RATIONALE: Preventing bone loss in patients who are undergoing androgen abl...
Status
Completed
Location
CCOP - Mayo Clinic Scottsdale Oncology Program
Start Date
2002-11
Trial ID
NCT00043069
Treatments Being Tested
The purpose of this study is to develop new treatment options for osteoporo...
Status
Completed
Location
Columbia University Medical Center, Harkness Pavilion
Start Date
2003-12
Trial ID
NCT01611571
Treatments Being Tested
Aromatase inhibitor therapy is in France the adjuvant reference treatment f...
Status
Completed
Location
Service de Rhumatology et de Pathologie Osseuse, Hôpital Edouard Herriot
Start Date
2009-11
Trial ID
NCT00859703
Treatments Being Tested